{
  "story_id": "ca5492382a05d39940b04aa88825d251",
  "desk": "drm3",
  "revision": 2,
  "published_at": "2026-09-03T18:00:07.000Z",
  "content_hash": "7ad00fd4c34a83fa9760d0e05249e1812c94be948ba418869fe398ee32f28a3f",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "Psilocybin Study Shows Potential to Prevent Chemotherapy-Induced Nerve Damage",
    "dek": "New research indicates psilocybin may protect mice from nerve damage caused by chemotherapy cycles.",
    "prose": "A study published in the journal Science on Thursday found that mice given two doses of psilocybin were protected against nerve damage caused by chemotherapy for up to six cycles of treatment. [^1]\n\nIn a study published in Science in 2026, researchers at The University of Texas MD Anderson Cancer Center reported that psilocybin administered before chemotherapy prevented the onset of chemotherapy-induced peripheral neuropathy in preclinical models, even across repeated chemotherapy cycles. [^2] The MD Anderson researchers found that psilocybin protects peripheral nerves through serotonin 5-HT2A receptors by preserving mitochondrial trafficking and energy delivery at nerve endings. [^3] Patrick Dougherty, a professor at the University of Texas MD Anderson Cancer Center, stated that this is the first time psilocybin has been used as a neuroprotective agent. [^4]\n\nResearchers plan to begin a clinical trial in about a month to test the hypothesis in patients with colorectal, breast, and head and neck cancers undergoing chemotherapy. [^5] The research team discovered that psilocybin helps maintain the movement of mitochondria along microtubules in nerve cells, which are attacked by chemotherapy. [^6] Blocking the serotonin 5-HT2A pathway reversed psilocybin's neuroprotective effects, while a non-hallucinogenic compound activating the same receptor produced protection similar to psilocybin. [^7]\n\nIn the preclinical models, two doses of psilocybin given before chemotherapy prevented hypersensitivity to cold, protected sensory nerve endings, and preserved touch sensation, while maintaining chemotherapy's antitumor activity. [^8]",
    "cited": "[{\"statement\":\"A study published in the journal Science on Thursday found that mice given two doses of psilocybin were protected against nerve damage caused by chemotherapy for up to six cycles of treatment.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"]},{\"statement\":\"In a study published in Science in 2026, researchers at The University of Texas MD Anderson Cancer Center reported that psilocybin administered before chemotherapy prevented the onset of chemotherapy-induced peripheral neuropathy in preclinical models, even across repeated chemotherapy cycles.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:07.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"The MD Anderson researchers found that psilocybin protects peripheral nerves through serotonin 5-HT2A receptors by preserving mitochondrial trafficking and energy delivery at nerve endings.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:07.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"Patrick Dougherty, a professor at the University of Texas MD Anderson Cancer Center, stated that this is the first time psilocybin has been used as a neuroprotective agent.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"]},{\"statement\":\"Researchers plan to begin a clinical trial in about a month to test the hypothesis in patients with colorectal, breast, and head and neck cancers undergoing chemotherapy.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"]},{\"statement\":\"The research team discovered that psilocybin helps maintain the movement of mitochondria along microtubules in nerve cells, which are attacked by chemotherapy.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"]},{\"statement\":\"Blocking the serotonin 5-HT2A pathway reversed psilocybin's neuroprotective effects, while a non-hallucinogenic compound activating the same receptor produced protection similar to psilocybin.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:07.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"In the preclinical models, two doses of psilocybin given before chemotherapy prevented hypersensitivity to cold, protected sensory nerve endings, and preserved touch sensation, while maintaining chemotherapy's antitumor activity.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T18:00:07.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": null,
  "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "06e835cf94c64ba2d4fc7023b07e0fd3",
      "thread_id": "b9ec7eb1a2be40bb756af16483a4961d",
      "thread_label": "Moran Amit",
      "novelty": "UPDATE",
      "content_hash": "f3ee1236836ec540c90eb6fc5b86685118b0db0f294e3e5eb5786cd2d04b3e47",
      "last_published_at": "2026-09-03T18:00:07.000Z",
      "read_receipt": {
        "slice_hash": "e89ee50692975bcab64631f7f6d4c1ede7d7ec2b39250c0c7f1b321a65934bd8",
        "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDNUMTc6NDM6MDAuMDAwMDAwWiIsImlkIjoiMDI0MTQ1MGM0ODc4ZDRlODllNTgwODIwMDk2NTIyYWQiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDNUMTg6MTU6MTcuMDAwMDAwWiIsImlkIjoiOWY0MzJhMmYyNjlmNTA4NzUxNDBiZWQ2NGY2YzJiNmMiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 12166856,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "aSd4-LRFiKn6BJHKt28qQugEjsnon85djJgciFJjYX4ukBTf6ZfgiyKzQPzXwTvyLGRGYEQbER3BHa32PqmHAA",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      },
      "compose": 3,
      "recomposed_at": "2026-09-05T20:25:44.662Z"
    },
    "written_at": "2026-09-04T06:35:05.693Z"
  },
  "cited_facts": [
    {
      "n": 1,
      "statement": "A study published in the journal Science on Thursday found that mice given two doses of psilocybin were protected against nerve damage caused by chemotherapy for up to six cycles of treatment.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 2,
      "statement": "In a study published in Science in 2026, researchers at The University of Texas MD Anderson Cancer Center reported that psilocybin administered before chemotherapy prevented the onset of chemotherapy-induced peripheral neuropathy in preclinical models, even across repeated chemotherapy cycles.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 3,
      "statement": "The MD Anderson researchers found that psilocybin protects peripheral nerves through serotonin 5-HT2A receptors by preserving mitochondrial trafficking and energy delivery at nerve endings.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 4,
      "statement": "Patrick Dougherty, a professor at the University of Texas MD Anderson Cancer Center, stated that this is the first time psilocybin has been used as a neuroprotective agent.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 5,
      "statement": "Researchers plan to begin a clinical trial in about a month to test the hypothesis in patients with colorectal, breast, and head and neck cancers undergoing chemotherapy.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 6,
      "statement": "The research team discovered that psilocybin helps maintain the movement of mitochondria along microtubules in nerve cells, which are attacked by chemotherapy.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 7,
      "statement": "Blocking the serotonin 5-HT2A pathway reversed psilocybin's neuroprotective effects, while a non-hallucinogenic compound activating the same receptor produced protection similar to psilocybin.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 8,
      "statement": "In the preclinical models, two doses of psilocybin given before chemotherapy prevented hypersensitivity to cold, protected sensory nerve endings, and preserved touch sensation, while maintaining chemotherapy's antitumor activity.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true. The dates on cited_facts (occurred_at, published_at) are the forge's, joined at read time; they are not part of the signed basis above."
}